Stock Events

Stock Events

Forte Biosciences 

€21.4
15
-€0.6-2.73% Thursday 06:05

Statistics

Day High
21.4
Day Low
21.4
52W High
28.4
52W Low
4.66
Volume
-
Avg. Volume
-
Mkt Cap
268.08M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18MayExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Next
Next
-6.13
-4.36
-2.59
-0.82
Expected EPS
-0.8837178
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-67.27MNet Income

Analyst Ratings

$47.80Average Price Target
The highest estimate is 49.32.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 37T.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals competes in the development of biologic drugs for skin diseases, similar to Forte Biosciences' focus on dermatology.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie has a strong portfolio in dermatology, including treatments for conditions that Forte Biosciences targets.
AMGEN
AMGN
Mkt Cap160.66B
Amgen has a presence in the dermatology market, competing with Forte Biosciences in developing treatments for skin conditions.
Journey Medical
DERM
Mkt Cap213.64M
Journey Medical Corporation (formerly Dermira) focuses on dermatological conditions, directly competing with Forte Biosciences' dermatology focus.
AnaptysBio
ANAB
Mkt Cap1.02B
AnaptysBio is involved in developing therapeutic antibodies for inflammatory diseases, including dermatological conditions, making it a competitor.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, through its acquisition of Immunomedics, competes in the biopharmaceutical space with a focus on treatments that could overlap with Forte Biosciences' interests.
Merck
MRK
Mkt Cap214.76B
Merck & Co. has a diversified portfolio that includes treatments for skin diseases, competing with Forte Biosciences in the dermatology space.
Pfizer
PFE
Mkt Cap140.15B
Pfizer has a broad range of healthcare products, including those for dermatological conditions, making it a competitor to Forte Biosciences.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its Janssen Pharmaceuticals segment, offers products for dermatology, competing with Forte Biosciences.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb has a diverse biopharmaceutical portfolio that includes treatments for skin diseases, competing with Forte Biosciences.

About

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Show more...
CEO
ISIN
US34962G2084
WKN
000A40MGA

Listings

F
DE
37T.F
XNAS
US
FBRX
BOATS
BOATS
FBRX.BOATS

0 Comments

Share your thoughts

FAQ

What is Forte Biosciences stock price today?▼
The current price of 37T.F is €21.4 EUR — it has decreased by -2.73% in the past 24 hours. Watch Forte Biosciences stock price performance more closely on the chart.
What is Forte Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Forte Biosciences stocks are traded under the ticker 37T.F.
Is Forte Biosciences stock price growing?▼
37T.F stock has fallen by -5.31% compared to the previous week, the month change is a -10.08% fall, over the last year Forte Biosciences has showed a +229.23% increase.
What is Forte Biosciences market cap?▼
Today Forte Biosciences has the market capitalization of 268.08M
When is the next Forte Biosciences earnings date?▼
Forte Biosciences is going to release the next earnings report on May 18, 2026.
What is Forte Biosciences revenue for the last year?▼
Forte Biosciences revenue for the last year amounts to 0 EUR.
What is Forte Biosciences net income for the last year?▼
37T.F net income for the last year is -67.27M EUR.
When did Forte Biosciences complete a stock split?▼
The last stock split for Forte Biosciences was on August 28, 2024 with a ratio of 1:25.